Sign In
Get Clay Free →

Suggestions

    Renu Bhatia

    Chairman at Opharmic Technology

    Renu Bhatia is a prominent figure in Hong Kong's financial and healthcare sectors, currently serving as the Chairman of the Listing Committee of the Hong Kong Stock Exchange (HKEX). Here's a comprehensive overview of her background and achievements:

    Professional Background

    HKEX Listing Committee: Renu Bhatia has been a member of the HKEX Listing Committee since 2019 and was appointed as its Chairman in 2023.12 She has been re-appointed to this position in 2024, highlighting her continued leadership in this crucial role.2

    Healthcare and Technology: Dr. Bhatia is the Chairman and co-founder of Opharmic Technology (HK) Ltd, a company developing ultrasound technology for non-invasive drug delivery to the eyes.34 This role showcases her expertise in healthcare innovation and entrepreneurship.

    Financial Sector: With over 25 years of experience, Dr. Bhatia has a diverse background spanning healthcare, finance, fintech, and regulatory sectors.4 She co-founded Asia Fintech Angels, which invests in early-stage fintech companies.4

    Education and Qualifications

    • Doctor of Medicine (MBBS) from the University of London
    • Master of Business Administration from Yale University
    • Postgraduate Diploma in Therapeutics and Medicine from The University of Hong Kong4

    Board Positions and Public Service

    • Independent Non-executive Director of Overstone Associates Limited
    • Member of the Business Professional Federation Healthcare Committee
    • Member of the Cyberport Entrepreneurship Centre Advisory Group
    • Assessor for the Hong Kong Enterprise Support Scheme Assessment Panel of the Innovation and Technology Fund4

    Career Journey

    Dr. Bhatia's career path is unique and multifaceted:

    1. Started as a medical doctor
    2. Transitioned to finance, working at Goldman Sachs and HSBC Asset Management
    3. Developed interests in healthcare economics and technology innovation
    4. Co-founded Opharmic Technology, combining her medical and business expertise
    5. Actively involved in fintech and regulatory roles, including her position at HKEX3

    Expertise and Contributions

    Dr. Bhatia brings a wealth of experience to her roles, particularly in:

    • Healthcare innovation and technology
    • Financial markets and regulations
    • Corporate governance
    • Board diversity and inclusion

    Her diverse background allows her to offer unique perspectives in board discussions and contribute to the development of Hong Kong's financial markets.3

    Dr. Bhatia is known for her proactive approach to seeking opportunities and her advocacy for board diversity. She emphasizes the importance of having diverse viewpoints and skills on boards to navigate complex business environments and improve corporate governance.3

    Highlights

    Aug 5 · youtube.com
    HKEX's #GetOnBoard Series: Renu Bhatia - YouTube
    HKEX's #GetOnBoard Series: Renu Bhatia - YouTube
    Jul 5 · hkex.com.hk
    Appointment of Listing Committee Members - HKEX
    May 8 · hutch-med.com
    HUTCHMED Announces Appointment of Independent Non ...
    Jul 7 · hkex.com.hk
    Appointment of Listing Committee Members - HKEX

    Related Questions

    What is Renu Bhatia's professional background before joining HKEX?
    How has Renu Bhatia's leadership impacted the Listing Committee at HKEX?
    What are the main responsibilities of the Listing Committee at HKEX?
    How often does the Listing Committee at HKEX undergo changes in membership?
    What qualifications are required to serve on the Listing Committee at HKEX?
    Renu Bhatia
    Renu Bhatia, photo 1
    Renu Bhatia, photo 2
    Get intro to Renu
    Add to my network

    Location

    Hong Kong SAR